FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036692299> ?p ?o ?g. }

• W2036692299 abstract "Background During the year 2013, the Spanish Agency for Medicines and Health Products (AEMPS) issued a series of alerts related to medicines containing tetrazepam: 1- Communication of start of the review process by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) as a result of new data about a higher frequency of cutaneous adverse reactions to tetrazepam, without any specific recommendation (January). 2- Recommendation not to exceed seven days when starting new treatment and to review prolonged treatment (April). 3- Decision to suspend the marketing, to not allow initiation of new treatments and to look for alternative drugs (June). Tetrazepam has been widely used in Spain since 1978. These alerts have forced a change in prescribing habits for indications of tetrazepam. Purpose To analyse prescribing trends for tetrazepam and therapeutic alternatives in response to safety alerts issued by AEMPS. Materials and methods Retrospective study of tetrazepam prescriptions and alternative treatment (AT) in the outpatients department of a 650-bed hospital that serves a population of 220,000 inhabitants. AT was defined as drugs in the tetrazepam therapeutic group (tizanidine, baclofen, cyclobenzaprine and methocarbamol) and benzodiazepines that shared indications (ketazolam and diazepam). We recorded the number of Defined Daily Doses (DDDs) of the drugs prescribed each month during two different periods: No Alerts Period (NAP), from January to August 2012, and Alerts Period (PA), from January to August 2013. To evaluate the influence of different alerts on prescribing, periods of a month either side of each notification were compared to 2012 (First period (FP): January, February and March, Second Period (SP): April and May and Third Period (TP): June, July and August). The global influence was analysed by comparing mean DDD/month between the NAP and the AP of each drug. Prescription data were obtained from the application for the registration and use of prescription-dispensing data of the Public Health System of Andalucia (Mycrostrategy). The Chi-squared test was applied to data. Results In the FP DDD of tetrazepam decreased from an average of 2247 DDD/month in 2012 to 1607 DDD/month, the sum of DDD of AT increased from 4028 DDD/month to 6028 DDD/month. During the SP tetrazepam prescribing decreased from 2090 DDD/month to 725 DDD/month and AT increased from 3988 DDD/month to 8303 DDD/month. In the TP tetrazepam use fell from 2197 DDD/month to 67 DDD/month and the AT increased from 3999 DDD/month to 9655 DDD/month. Globally tetrazepam DDD decreased from 2189 month in NAP to 809 DDD/month in the PA, 63% reduction (p Conclusions The publication of alerts has reduced the use of tetrazepam by our doctors in a phased manner. Prescriptions were diverted to their AT, causing a significant increase in their use. Diazepam was the most used AT. No conflict of interest." @default.
• W2036692299 created "2016-06-24" @default.
• W2036692299 creator A5007323950 @default.
• W2036692299 creator A5008785679 @default.
• W2036692299 creator A5011068530 @default.
• W2036692299 creator A5025842506 @default.
• W2036692299 creator A5037626500 @default.
• W2036692299 creator A5053849933 @default.
• W2036692299 creator A5057703415 @default.
• W2036692299 creator A5064084299 @default.
• W2036692299 creator A5070164488 @default.
• W2036692299 creator A5091584253 @default.
• W2036692299 date "2014-02-24" @default.
• W2036692299 modified "2023-09-26" @default.
• W2036692299 title "DI-082 Evolution of tetrazepam prescriptions after safety warnings issued in Spain" @default.
• W2036692299 doi "https://doi.org/10.1136/ejhpharm-2013-000436.253" @default.
• W2036692299 hasPublicationYear "2014" @default.
• W2036692299 type Work @default.
• W2036692299 sameAs 2036692299 @default.
• W2036692299 citedByCount "0" @default.
• W2036692299 crossrefType "journal-article" @default.
• W2036692299 hasAuthorship W2036692299A5007323950 @default.
• W2036692299 hasAuthorship W2036692299A5008785679 @default.
• W2036692299 hasAuthorship W2036692299A5011068530 @default.
• W2036692299 hasAuthorship W2036692299A5025842506 @default.
• W2036692299 hasAuthorship W2036692299A5037626500 @default.
• W2036692299 hasAuthorship W2036692299A5053849933 @default.
• W2036692299 hasAuthorship W2036692299A5057703415 @default.
• W2036692299 hasAuthorship W2036692299A5064084299 @default.
• W2036692299 hasAuthorship W2036692299A5070164488 @default.
• W2036692299 hasAuthorship W2036692299A5091584253 @default.
• W2036692299 hasConcept C108170787 @default.
• W2036692299 hasConcept C111472728 @default.
• W2036692299 hasConcept C138885662 @default.
• W2036692299 hasConcept C197636746 @default.
• W2036692299 hasConcept C197934379 @default.
• W2036692299 hasConcept C2426938 @default.
• W2036692299 hasConcept C2908647359 @default.
• W2036692299 hasConcept C545542383 @default.
• W2036692299 hasConcept C57658597 @default.
• W2036692299 hasConcept C71924100 @default.
• W2036692299 hasConcept C98274493 @default.
• W2036692299 hasConcept C99454951 @default.
• W2036692299 hasConceptScore W2036692299C108170787 @default.
• W2036692299 hasConceptScore W2036692299C111472728 @default.
• W2036692299 hasConceptScore W2036692299C138885662 @default.
• W2036692299 hasConceptScore W2036692299C197636746 @default.
• W2036692299 hasConceptScore W2036692299C197934379 @default.
• W2036692299 hasConceptScore W2036692299C2426938 @default.
• W2036692299 hasConceptScore W2036692299C2908647359 @default.
• W2036692299 hasConceptScore W2036692299C545542383 @default.
• W2036692299 hasConceptScore W2036692299C57658597 @default.
• W2036692299 hasConceptScore W2036692299C71924100 @default.
• W2036692299 hasConceptScore W2036692299C98274493 @default.
• W2036692299 hasConceptScore W2036692299C99454951 @default.
• W2036692299 hasLocation W20366922991 @default.
• W2036692299 hasOpenAccess W2036692299 @default.
• W2036692299 hasPrimaryLocation W20366922991 @default.
• W2036692299 hasRelatedWork W1588158731 @default.
• W2036692299 hasRelatedWork W1955743710 @default.
• W2036692299 hasRelatedWork W1969092028 @default.
• W2036692299 hasRelatedWork W1989437387 @default.
• W2036692299 hasRelatedWork W2015038977 @default.
• W2036692299 hasRelatedWork W2074102731 @default.
• W2036692299 hasRelatedWork W2089742904 @default.
• W2036692299 hasRelatedWork W2090460624 @default.
• W2036692299 hasRelatedWork W2115027765 @default.
• W2036692299 hasRelatedWork W2147607100 @default.
• W2036692299 hasRelatedWork W2218993850 @default.
• W2036692299 hasRelatedWork W2352568261 @default.
• W2036692299 hasRelatedWork W2398693841 @default.
• W2036692299 hasRelatedWork W2409440345 @default.
• W2036692299 hasRelatedWork W2410104511 @default.
• W2036692299 hasRelatedWork W2418548117 @default.
• W2036692299 hasRelatedWork W2432471085 @default.
• W2036692299 hasRelatedWork W3080989471 @default.
• W2036692299 hasRelatedWork W333272864 @default.
• W2036692299 hasRelatedWork W2154267247 @default.
• W2036692299 isParatext "false" @default.
• W2036692299 isRetracted "false" @default.
• W2036692299 magId "2036692299" @default.
• W2036692299 workType "article" @default.